In spite of the widespread use of obstetrical sonography, the prenatal detection of presumed adrenal hemorrhage remains extremely unPathologic proof is ~a r e .~,~ Several authors have noted adrenal calcifications at birth and have speculated that they represent the sequelae of prenatal adrenal hemorrhage. However, without pathologic proof, differentiation from spontaneously resolved neuroblastoma is not pos~i b l e .~-~
We present a case of adrenal hemorrhage initially detected as a predominantly cystic mass with prenatal sonography at 28 weeks. The mass persisted on sequential prenatal sonograms with an increase in size and a change in internal architecture, from primarily cystic to complex with cystic and solid elements. Postnatal sonography and computed tomography (CT) on the first day of life confirmed a complex cystic and solid mass. Persistence of a suprarenal mass without significant decrease in size, in combination with a complex sonographic appearance, led to a presurgical diagnosis of cystic neuroblastoma; however, adrenal hemorrhage was found at surgery.
CASE REPORT
A 28-year-old woman (gravida 5, para 1, spontaneous abortion 3) had unremarkable sonograms at 6 weeks and 14 weeks, menstrual age (MA). At kidney was inferiorly displaced by the mass (Figure 2B ). The fetal survey was otherwise normal, as was the amniotic fluid volume.
A 3,500 g baby boy was born at 37 weeks, MA, by an uneventful elective cesarean section. The physical examination of the neonate was unremarkable. No calcifications or masses were detected on abdominal radiographs. Sonography on the first day of life confirmed a complex cystic and solid mass in the left upper quadrant, inferior to the spleen and displacing the left kidney inferiorly (Figure 3) . CT, also performed on the first day of life, showed a primarily cystic mass with a discernible rim and faint internal septations (Figure 4) . On both postnatal sonogram and CT the mass was spherical, measuring approximately 4.7 cm in diameter. The findings were thought to most likely represent a cystic neuroblastoma, with adrenal hemorrhage being considered unlikely given the lack of significant decrease in size over 9 weeks and the complex sonographic appearance. On the third day of life, the infant underwent surgical excision of a cystic mass arising from the left adrenal gland. Pathology revealed a hemorrhagic cyst, with no evidence of neoplasm on careful examination. The patient recovered uneventfully. is also valuable in excluding the presence of neuroblastoma."
There have been four prior reported cases of adrenal hemorrhage detected with prenatal sonography between 23 weeks and 36 weeks, Two of these cases had pathologic proof; the other two were presumed based on follow-up studies. Gotoh et a1 reported a 3.6 cm cystic mass detected with prenatal sonography at 36 weeks, MA.' A presumed diagnosis of adrenal hemorrhage based on a decrease in size by sonography 3 weeks postnatally, absence of metastases, normal urinary homovanillic acid (HVA) and vanillylmandelic acid (VMA) levels, and eventual calcification by 5 months. Marino et a1 reported a 5 cm x 3 cm cystic mass at 24 weeks, MA, which was pathologically proven t o be an adrenal hemorrhage following postnatal surgery.2 Lee et a1 reported a 3.6 cm x 3.2 cm "hypoechoic" mass identified with prenatal sonography at 32 weeks, MA.3 A presumed diagnosis of adrenal hemorrhage was based on decrease in size and eventual resolution on serial postnatal ~onography.~ Noe and Angel reported a 2.5 cm suprarenal mass, echogenic on both prenatal (23 weeks, MA) and VOL. 23, NO. 7, SEPTEMBER 1995 postnatal sonography, and surgically confirmed to be an adrenal h e m~r r h a g e .~ Three authors have postulated that adrenal calcifications detected at birth represent the sequelae of prenatal adrenal but none of these cases were proven pathologically.
Prior non-pathologically proven cases of presumed adrenal hemorrhage are controversial because of the natural history of neuroblastoma in the neonatal age group and the overlap of the sonographic and radiographic characteristics of the two lesions. It has been widely published that neuroblastoma in the neonate or child of younger than 2 years of age carries a better prognosis than neuroblastoma in the older child." Spontaneous resolution can occur, especially with stage IVs disease.12 Incidental or "in situ" neuroblastoma is a proven phen0men0n.l~ Eklof et a1 reported 11 cases of "concomitant" neonatal adrenal hemorrhage and neuroblastoma. l4 It is not clear whether the hemorrhages were truly concomitant or actually secondary t o neuroblastoma. One would expect these lesions to behave, at least in part, like adrenal hemorrhage when examined sonographically. Neonatal neuroblastoma can also be cystic, simulating an evolving adrenal hemorrhage.15 Reinberg reported a solid appearing neuroblastoma which decreased in size on subsequent sonograms, a finding usually considered reliable evidence of adrenal hemorrhage.16 The sonographic diagnosis of neonatal adrenal hemorrhage thus remains an assumptive one, based on the typical sonographic course. Follow-up to sonographic resolution and correlation with urinary catecholamines should suffice to exclude clinically significant neuroblastoma.
Diagnosing prenatal adrenal hemorrhage on the basis of adrenal calcifications detected at birth is also controversial. Fifty to seventy-five percent of neuroblastomas contain calcification. Neuroblastoma in the neonate, and presumably in the fetus, can spontaneously resolve or exist in sit^.'^,'^ Therefore, it is possible that calcifications presumed to represent the sequelae of prenatal adrenal hemorrhage actually represent the residua of spontaneously resolved neuroblastoma or neuroblastoma in situ.
As there is unequivocal proof that prenatal adrenal hemorrhages do occur, suprarenal masses detected in utero can be followed postnatally in a similar fashion to those detected postnatally, assuming the infant's urinary HVA and VMA levels are normal. A solid or complex suprarenal mass which subsequently becomes sonolucent and shrinks on follow-up sonograms, prenatally and postnatally, is most consistent with adrenal hemorrhage. Should the mass grow, fail to resolve, or have other characteristics suspicious for neuroblastoma, even with normal urinary HVA and VMA levels (10% of patients with neuroblastoma have normal HVA, 27.5% have normal VMA"), then additional imaging and possible surgical intervention should be considered.
Our case is only the third report of pathologically proven prenatal adrenal hemorrhage. The sonographic appearance in this case differs from prior reported cases. Although initially detected at 28 weeks, MA, as a primarily cystic lesion, by 32 weeks it had evolved to a complex cystic and solid sonographic appearance. Although a lesion that changes on serial sonograms from cystic to semisolid is frequently adrenal hemorrhage, this can also be seen with neuroblastoma, particularly with associated hemorrhage. Due to the complex appearance and a lack of significant decrease in size in postnatal examinations, a cystic neuroblastoma was suspected and surgery was performed in the reported case. Even with the knowledge that prenatal adrenal hemorrhages do occur, it is unlikely that surgery could have been averted because the lesion did not follow the typ-446 ical sonographic course of adrenal hemorrhage. This may represent a different physiology of adrenal hemorrhage occurring in utero, or recurrent hemorrhages contributing to a confusing sonographic appearance.
In conclusion, prenatal adrenal hemorrhage does occur. Prenatal adrenal hemorrhage has a variable sonographic appearance. Prenatally detected suprarenal masses may be investigated and followed clinically and radiographically similar to postnatally detected suprarenal masses.
